Autopsy report · NCT04743232

COVID-19 Resuscitation Plans and Decisions on Escalation and Limitation of Treatment

“Because the COVID pandemic became less severe (omikron)”

The sponsor’s own words in the registry.

Life of this trial

• Suspended: paused, and may or may not restart.
• 200 participants enrolled.

Vital statistics

Status

Suspended

Phase

Na

Sponsor

Erasmus Medical Center

Sponsor type

University, hospital or other

Conditions

Covid19; Cardiac Arrest

Interventions

Decision tool for clinicians

Participants

200

Sites

7

Countries

Netherlands

Trials that died the same way

• Effect of Global Postural Re-education in Idiopathic Scoliosis
  “Because of the COVID-19 pandemic” (77% match in meaning)
• Effects of Stoss Therapy of Vitamin D3 on Peri-operative Outcomes in Patients Receiving General Surgery
  “Because of impact from COVID-19 pandemic” (77% match in meaning)
• Wellbeing and Stress Among Mobile Phone Dispatched Lay Responders
  “Due to the COVID-19 Pandemic.” (74% match in meaning)
• Suicide Prevention in Prepubertal Children
  “Due to COVID-19 Pandemic” (72% match in meaning)
• Virtual Reality for the Treatment of Chronic Low Back Pain
  “Due to the impact of COVID-19” (68% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.